Reclassifying TNM stage I/II colorectal cancer into two subgroups with different overall survival, tumor microenvironment, and response to immune checkpoint blockade treatment

Background: The traditional TNM staging system is often insufficient to differentiate the survival discrepancies of colorectal cancer (CRC) patients at TNM stage I/II. Our study aimed to reclassify stage I/II CRC patients into several subgroups with different prognoses and explore their suitable the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiangxiang, Qin, Jian, Nie, Junjie, Sun, Huiling, Pan, Yuqin, Wang, Shukui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532767/
https://www.ncbi.nlm.nih.gov/pubmed/36212126
http://dx.doi.org/10.3389/fgene.2022.948920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532767/
https://www.ncbi.nlm.nih.gov/pubmed/36212126
http://dx.doi.org/10.3389/fgene.2022.948920

Ejemplares similares